Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBKEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBKEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBKENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.14.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.14.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.14.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.14.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.14.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.14.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DT.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DT.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DT.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DT.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DT.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DT.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DT.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DS.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DS.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DS.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used